Mapath Capital Corp.
IVFZF
$0.005
$0.00494,900.00%
| Weiss Ratings | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -28.67 | |||
| Price History | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 4,900.00% | |||
| 2-Year Total Return | 4,900.00% | |||
| 3-Year Total Return | -75.00% | |||
| 5-Year Total Return | -90.74% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Oct 29, 2024 | |||
| 52-Week High Price (Date) | Oct 29, 2024 | |||
| Valuation | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 130.62K | |||
| Enterprise Value | 189.37K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -39.34% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.28 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -2.31 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 26.12M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 778 383 1690 | |||
| Address | 1090 West Georgia St Vancouver, BC V6E 3V7 | |||
| Website | -- | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -140.76% | |||
| Return on Equity | -- | |||
| Income Statement | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -79.50K | |||
| Net Income (TTM) | -95.50K | |||
| Net Income Avl. to Common (TTM) | -95.50K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -20.86% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -33.33% | |||
| Balance Sheet | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 10.50K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -461.00K | |||
| Current Ratio (Q) | 0.026 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 10.50K | |||
| Total Current Liabilities (Q) | 407.80K | |||
| Total Debt (Q) | 63.60K | |||
| Total Liabilities (Q) | 471.40K | |||
| Total Common Equity (Q) | -461.00K | |||
| Cash Flow | IVFZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -11.20K | |||
| Net Change in Cash (TTM) | -49.60K | |||
| Levered Free Cash Flow (TTM) | -9.10K | |||
| Cash from Operations (TTM) | -38.10K | |||
